Redefining value in drug development and clinical research

The Tufts Center for the Study of Drug Development, a nonprofit research group affiliated with Tufts University School of Medicine, analyzed the financial and operational impact of aligning manufacturing, clinical research, laboratory, and supply chain services under a single provider.

To assess value, Tufts developed a model using real-world clinical trial data and industry benchmarks focused on projected outcomes in oncology programs across both monoclonal antibodies (mAbs) and small molecules.